How pancreatic polypeptide affects appetite fullness in healthy men
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether pancreatic polypeptide (a natural hormone) changes how full you feel when combined with another hormone called amylin. It may help us understand appetite control in healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male
- You are between 18 and 65 years old
- Your body mass index (BMI) is between 18 and 27
- Your body fat percentage is less than 20%
- You have no history of liver, gallbladder, stomach, or intestine problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
This study looks at how a natural gut hormone called GIP affects blood pressure after a meal. It may help find new ways to treat blood pressure problems after eating.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
This study tests whether a natural supplement can help regulate blood sugar and metabolism in adults who are overweight but otherwise healthy. Participants will receive either the supplement or a placebo to see if it affects appetite and glucose levels.
This study tests two weekly hormone injections (GIP and amylin) to see how they affect stomach-related side effects in people who are overweight or obese. Researchers want to understand if these hormones can help manage weight or related symptoms.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.